AU2001264522A1 - Methods and compositions for the prevention of myopia - Google Patents

Methods and compositions for the prevention of myopia

Info

Publication number
AU2001264522A1
AU2001264522A1 AU2001264522A AU6452201A AU2001264522A1 AU 2001264522 A1 AU2001264522 A1 AU 2001264522A1 AU 2001264522 A AU2001264522 A AU 2001264522A AU 6452201 A AU6452201 A AU 6452201A AU 2001264522 A1 AU2001264522 A1 AU 2001264522A1
Authority
AU
Australia
Prior art keywords
myopia
prevention
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001264522A
Inventor
Bahram Resul
Johan Stjernschantz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synphora AB
Original Assignee
Synphora AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synphora AB filed Critical Synphora AB
Publication of AU2001264522A1 publication Critical patent/AU2001264522A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001264522A 2000-06-13 2001-06-13 Methods and compositions for the prevention of myopia Abandoned AU2001264522A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0002211A SE0002211D0 (en) 2000-06-13 2000-06-13 Methods and compositions for prevention of myopia
SE0002211 2000-06-13
PCT/SE2001/001339 WO2001095913A1 (en) 2000-06-13 2001-06-13 Methods and compositions for the prevention of myopia

Publications (1)

Publication Number Publication Date
AU2001264522A1 true AU2001264522A1 (en) 2001-12-24

Family

ID=20280076

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001264522A Abandoned AU2001264522A1 (en) 2000-06-13 2001-06-13 Methods and compositions for the prevention of myopia

Country Status (3)

Country Link
AU (1) AU2001264522A1 (en)
SE (1) SE0002211D0 (en)
WO (1) WO2001095913A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01013257A (en) * 2001-12-18 2003-06-25 Arturo Jimenez Bayardo Rofecoxib ophthalmic suspension for the treatment of ocular inflammation and pain.
US7074827B2 (en) 2002-10-24 2006-07-11 Sucampo Ag (Usa) Inc. Method for treating ocular hypertension and glaucoma
WO2005051413A2 (en) * 2003-11-26 2005-06-09 Novartis Ag Disease associated genes
CN102078614B (en) * 2010-12-27 2012-07-25 温州医学院眼视光研究院 Method for inhibiting shortsightedness and application of adenylate cyclase inhibitor as medicament for inhibiting shortsightedness
EP2694077A4 (en) * 2011-04-07 2015-01-21 Sucampo Ag Method for treating asthenopia
WO2014182620A1 (en) * 2013-05-06 2014-11-13 Kaohsiung Chang Gung Memorial Hospital Pharmaceutical composition and uses thereof
TWI658828B (en) * 2014-10-31 2019-05-11 中國醫藥大學 Pharmaceutical composition for soothing and reducing myopia, and preparation method and application thereof
CN105998030A (en) * 2016-05-17 2016-10-12 温州医科大学 Application of prostaglandin F2a receptor stimulant in preparation of drug for inhibiting myopia and application method of prostaglandin F2a receptor stimulant
CA3031370A1 (en) 2016-08-19 2018-02-22 Orasis Pharmaceuticals Ltd. Ophthalmic pharmaceutical compositions and uses relating thereto

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519030A (en) * 1993-10-07 1996-05-21 Senju Pharmaceutical Co., Ltd. Method for prophylaxis and treatment of myopia
AU5805998A (en) * 1997-01-02 1998-07-31 Allergan Sales, Inc. Method for changing the refractive power of an eye
AU5312198A (en) * 1997-01-06 1998-08-03 Klaus Trier Aps Screening method
WO1999018970A1 (en) * 1997-10-14 1999-04-22 Senju Pharmaceutical Co., Ltd. Preventives and remedies for ophthalmic circulatory disturbance

Also Published As

Publication number Publication date
SE0002211D0 (en) 2000-06-13
WO2001095913A1 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
NZ514350A (en) Compositions and methods for effecting the levels of cholesterol
AUPR105400A0 (en) Processes and compositions for water treatment
AU2001239052A1 (en) Compositions for prevention and treatment of dementia
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
WO2000066104A3 (en) Ace-2 inhibiting compounds and methods of use thereof
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
AU2002225894A1 (en) Methods and compositions for the control of coccidiosis
AU2001250821A1 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
AU2001271031A1 (en) Cosmetic compositions for reducing and method of using the same
AU2001224021A1 (en) Compositions for protecting plants and method of using the same
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
AU2756301A (en) Compositions comprising genome segments and methods of using the same
AU2002303552A1 (en) Methods and compositions for prevention of angioproliferation
AU2002366809A1 (en) Syn3 compositions and methods
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2001255580A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2000265105A1 (en) Methods and compositions for the prevention and treatment of syndrome x
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases
AU2001253469A1 (en) Compositions and methods for stabilizing modified tissue
AU5931300A (en) Ringene compositions and methods for use thereof
AU2002359869A1 (en) Pak5-related compositions and methods